Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Sonja Loges, Bjorn Torre Gjertsen, Michael Heuser, I Ben-Batalla, David Micklem, Chromik Jorg, Maxim Kebenko, Walter M. Fiedler, Jorge E. Cortes | ||||||||||||
Title | A first-in-patient phase I study of BGB324, a selective Axl kinase inhibitor in patients with refractory/relapsed AML and high-risk MDS. | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/170403-176 | ||||||||||||
Abstract Text | J Clin Oncol 34, 2016 (suppl; abstr 2561) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|